Back to today’s briefing

Story perspectives

Biden Administration Proposes Medicare Coverage for Weight-Loss Drugs

1/31/2025

41 3

Summary

Story summary

The Biden administration is taking a bold step to support millions of Americans struggling with obesity by proposing to include weight-loss drugs like Wegovy and Ozempic in Medicare coverage. This initiative, projected to cost $35 billion over the next decade, not only enhances access to vital treatments but also boosts stock prices for companies like Eli Lilly and Novo Nordisk as demand surges.

1 of 1

Story summary

The Biden administration is taking a bold step to support millions of Americans struggling with obesity by proposing to include weight-loss drugs like Wegovy and Ozempic in Medicare coverage. This initiative, projected to cost $35 billion over the next decade, not only enhances access to vital treatments but also boosts stock prices for companies like Eli Lilly and Novo Nordisk as demand surges.